SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-051334
Filing Date
2018-09-28
Accepted
2018-09-27 20:13:57
Documents
2
Period of Report
2018-09-24
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv503572_8k.htm 8-K 20304
2 EXHIBIT 16.1 tv503572_ex16-1.htm EX-16.1 2504
  Complete submission text file 0001144204-18-051334.txt   24058
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 181092281
SIC: 2836 Biological Products, (No Diagnostic Substances)